Greenwich Wealth Management’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3K Buy
+368
New +$7.78K ﹤0.01% 307
2022
Q4
Sell
-12
Closed -$7K 244
2022
Q3
$7K Buy
12
+1
+9% +$785 ﹤0.01% 235
2022
Q2
$8K Buy
11
+2
+22% +$3.14K ﹤0.01% 232
2022
Q1
$31K Buy
9
+2
+29% +$5.24K ﹤0.01% 236
2021
Q4
$20K Sell
7
-10
-59% -$46.4K ﹤0.01% 243
2021
Q3
$113K Buy
17
+5
+42% +$43.2K 0.01% 236
2021
Q2
$162K Buy
12
+3
+33% +$47.2K 0.01% 219
2021
Q1
$156K Buy
9
+1
+13% +$19.5K 0.01% 199
2020
Q4
$138K Buy
8
+1
+14% +$18.8K 0.01% 188
2020
Q3
$139K Buy
7
+2
+40% +$46K 0.02% 184
2020
Q2
$141K Sell
5
-2
-29% -$56.7K 0.03% 179
2020
Q1
$148K Sell
7
-1
-13% -$16K 0.03% 173
2019
Q4
$76K Buy
8
+2
+33% +$19.3K 0.02% 186
2019
Q3
$53K Buy
6
+1
+20% +$12.2K 0.01% 177
2019
Q2
$83K Buy
5
+1
+25% +$16.6K 0.01% 193
2019
Q1
$84K Buy
+4
New +$71.1K 0.01% 185

Other funds holding KALA

Greenwich Wealth Management's KALA Position: Q1 2026 in Review

Greenwich Wealth Management opened a new position in KALA BIO (KALA) in Q1 2026: 368 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #307 among its holdings. This is a return to the name: Greenwich Wealth Management previously reported a position in KALA as recently as Q3 2022.

Greenwich Wealth Management first reported a position in KALA in Q1 2019 and has held it in 16 quarters since. The position peaked at $162K in Q2 2021. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Greenwich Wealth Management held 368 shares of KALA BIO worth $3K as of Q1 2026.
  • KALA BIO was a new Greenwich Wealth Management position in Q1 2026.
  • KALA BIO made up ﹤0.01% of Greenwich Wealth Management's portfolio in Q1 2026, its #307 holding.
  • Greenwich Wealth Management first reported a position in KALA BIO in Q1 2019 and has held it in 16 quarters since.
  • Greenwich Wealth Management's KALA BIO position peaked at $162K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.